🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a safety and efficacy study evaluating a experimental treatment for...
Status
Completed
Location
Site Reference ID/Investigator# 75139
Start Date
2012-05
Trial ID
NCT01655680
SPH3127 tablet is a of renin inhibitor. It is expected to be a new drug for...
Status
Completed
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2019-01-11
Trial ID
NCT03756103
Treatments Being Tested
This Phase 2 trial will evaluate the safety and efficacy of ABP-450 for the...
Status
Completed
Location
Arizona Neuroscience Research
Start Date
2021-03-29
Trial ID
NCT04849988
This study has the objective to demonstrate the effectiveness of Alacramyn ...
Status
Completed
Location
CHU Hassan II de Fès
Start Date
2018-07-21
Trial ID
NCT01336660
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-19
Trial ID
NCT02298179
Treatments Being Tested
The study is divided into 2 parts. In the first part, the safety of the gen...
Status
Completed
Location
University of California at San Diego Medical Center
Start Date
2007-03
Trial ID
NCT00454818
The primary objectives of the study are: * To evaluate the safety and tole...
Status
Completed
Location
Research Site
Start Date
2013-09
Trial ID
NCT01987843
Treatments Being Tested
The purpose of this study is to assess the safety profile of the Zaire Ebol...
Status
Completed
Location
Optimal Research
Start Date
2015-12-22
Trial ID
NCT02718469
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of K-134 f...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00783081
Treatments Being Tested
The purpose of the study is to evaluate the effects of growth hormone (GH) ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2004-08
Trial ID
NCT00182091
Treatments Being Tested